Mogens Vyberg

Hvidovre, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Distinct and complementary metabolic effects of GLP-1 and glucagon receptor agonism in diet-induced obese mice.

Distinct and complementary metabolic effects of GLP-1 and glucagon receptor agonism in diet-induced obese mice.

Journal: Peptides

Published: November 03, 2025

Decoding fibrosis: Transcriptomic and clinical insights via AI-derived collagen deposition phenotypes in MASLD.

Decoding fibrosis: Transcriptomic and clinical insights via AI-derived collagen deposition phenotypes in MASLD.

Journal: Hepatology (Baltimore, Md.)

Published: September 24, 2025

Diagnostics of Autoimmune Hepatitis Enabled by Non-Invasive Clinical Proteomics.

Diagnostics of Autoimmune Hepatitis Enabled by Non-Invasive Clinical Proteomics.

Journal: Alimentary pharmacology & therapeutics

Published: March 07, 2025

Alterations in one-carbon metabolism in metabolic dysfunction associated steatotic liver disease may be modified by semaglutide.

Alterations in one-carbon metabolism in metabolic dysfunction associated steatotic liver disease may be modified by semaglutide.

Journal: Annals of hepatology

Published: January 02, 2025

Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis.

Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis.

Journal: eLife

Published: October 03, 2024

Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease.

Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: August 06, 2024

The hepatic transcriptome is differentially regulated by a standardized meal in healthy individuals compared to patients with fatty liver disease.

The hepatic transcriptome is differentially regulated by a standardized meal in healthy individuals compared to patients with fatty liver disease.

Journal: PloS one

Published: July 22, 2024

Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease.

Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: April 16, 2024

Circulating and hepatic levels of growth differentiation factor 15 in patients with metabolic dysfunction-associated steatotic liver disease.

Circulating and hepatic levels of growth differentiation factor 15 in patients with metabolic dysfunction-associated steatotic liver disease.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: January 11, 2024

Societal costs and survival of patients with biopsy-verified non-alcoholic steatohepatitis: Danish nationwide register-based study.

Societal costs and survival of patients with biopsy-verified non-alcoholic steatohepatitis: Danish nationwide register-based study.

Journal: Annals of hepatology

Published: October 11, 2023

Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis.

Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis.

Journal: Scientific reports

Published: September 14, 2023

Postprandial dysfunction in fatty liver disease.

Postprandial dysfunction in fatty liver disease.

Journal: Physiological reports

Published: December 21, 2022

Showing 1-12 of 86

Last Updated: 09/26/2026